Viz.ai
The proven AI-powered care coordination platform
Overview
Viz.ai is one of the most established names in clinical AI imaging, with FDA-cleared algorithms and thousands of hospital deployments focused on stroke and neurovascular care coordination. Its core value is speed: shaving minutes off the time between a scan and a specialist seeing it can materially change patient outcomes in conditions like large vessel occlusion strokes, and Viz.ai has published clinical validation data to back that up rather than relying only on marketing claims.
The tradeoff is that Viz.ai is a deep hospital-system integration, not a lightweight SaaS tool, so evaluating it means working through imaging infrastructure, EHR ties, and Medicare reimbursement codes alongside a sales and clinical validation process. It's also a narrower category than a general-purpose AI product, focused specifically on time-critical disease detection rather than broad diagnostic imaging or general radiology workflows, so buyers should be clear that its strength is coordination speed, not being an all-purpose imaging AI suite.
Key Features
Viz LVO Detection: Automatically flags suspected large vessel occlusions from CT scans within seconds of image acquisition.
Care Coordination Alerts: Pushes real-time notifications to the relevant specialist's phone, with roughly 90% of alerts reviewed within 5 minutes.
Viz Neuro Suite: Broader neurovascular disease detection and workflow tools beyond stroke, including hemorrhage detection.
FDA-Cleared Algorithms: Multiple clinical algorithms cleared by the FDA and reimbursable under specific Medicare codes.
Clinical Validation Data: Published studies showing reduced door-to-treatment times and improved patient outcome scores (mRS).
Pricing
Starting price
Custom pricing only, contact sales
Enterprise/Custom: No public pricing tiers; hospitals and health systems work with Viz.ai's sales and clinical teams for a custom quote tied to imaging volume and modules used.
Disclaimer: pricing may change, confirm on Viz.ai's own site or via sales before buying.
Pros
FDA-Cleared and Clinically Validated: Backed by published outcome studies, not just vendor claims, in a space where clinical trust matters enormously.
Fast Specialist Alerting: Real-world data shows most alerts reaching the right specialist within minutes of image acquisition.
Large Installed Base: Trusted by thousands of hospitals, giving it strong reference-ability and a mature support ecosystem.
Reimbursement Pathway: Existing Medicare codes for stroke care coordination help justify the investment financially.
Cons
No Public Pricing: Entirely custom enterprise quotes, so smaller or budget-constrained facilities can't easily gauge affordability upfront.
Narrow Clinical Focus: Strongest in stroke/neurovascular detection; not a general-purpose radiology AI platform.
Heavy Integration Lift: Requires alignment with hospital imaging systems, EHRs, and clinical workflows, meaning long procurement and implementation cycles.
What Makes It Unique
Clinical Validation Depth: Few AI imaging tools have as much peer-reviewed, published outcomes data tied to specific FDA-cleared algorithms as Viz.ai does for stroke care.
Kay Score
7.8
/ 10
